Lv1
18 积分 2026-07-15 加入
Progress in the development of cytokine armoured CAR T cells
56分钟前
待确认
Priming treatment with T-cell redirecting bispecific antibody ERY974 reduced cytokine induction without losing cytotoxic activity in vitro by changing the chromatin state in T cells
1个月前
已完结
Nonclinical Toxicology, Biodistribution, and Pharmacokinetics of UB-VV111, an In Vivo Anti-CD19 CAR T Cell Therapy
1个月前
已完结
Promises and potential pitfalls of in vivo CAR gene therapy
1个月前
已完结
Unlocking the potential of T cell engagers in solid tumors
1个月前
已完结